ALLURION TECHNOLOGIES INC
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
ALUR$0.67-5.6%Stored close · as of Mar 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
UNAUDITED CONDENSED CONSOLI DATED STATEMENTS OF CASH FLOWS
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating Activities: | ||
| Net income (loss) | $5,586 | $(17,801) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Non-cash lease expense | 199 | 209 |
| Depreciation and amortization | 367 | 245 |
| Stock-based compensation | 552 | 409 |
| Provision for uncollectible accounts | — | 999 |
| Unrealized exchange (gain) or loss | 314 | (88) |
| Provision for inventory | 209 | — |
| Change in fair value of warrant liabilities | (3,131) | 1,475 |
| Change in fair value of derivative liabilities | 62 | 29 |
| Change in fair value of Revenue Interest Financing and PIPE Conversion Option | (1,490) | — |
| Change in fair value of earn-out liabilities | (14,190) | — |
| Non-cash interest expense | 315 | 317 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 1,673 | (427) |
| Inventory | 330 | (449) |
| Prepaid expenses, other current and long-term assets | 244 | 36 |
| Lease liabilities | (238) | (175) |
| Accounts payable | 1,551 | 5,354 |
| Accrued expenses and other current liabilities | (989) | (451) |
| Net cash used in operating activities | $(8,636) | $(10,318) |
| Investing Activities: | ||
| Purchases of property and equipment | (104) | (277) |
| Net cash used in investing activities | $(104) | $(277) |
| Financing Activities: | ||
| Proceeds from issuance of convertible notes - net | — | 13,600 |
| Proceeds from option and warrant exercises | 9 | 32 |
| Proceeds from equity line financing | 378 | — |
| Payment of deferred financing costs | — | (766) |
| Net cash provided by financing activities | $387 | $12,866 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | $(8,353) | $2,271 |
| Cash and cash equivalents and restricted cash at beginning of period | 38,421 | 8,023 |
| Cash and cash equivalents and restricted cash at end of period | $30,068 | $10,294 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $1,831 | $1,920 |
| Supplemental cash flow information on non-cash investing and financing activities | ||
| Purchase of property and equipment included in accounts payable | $73 | $174 |
| Deferred financing costs in accounts payable and accrued expenses | — | 2,634 |
| Change in fair value of Revenue Interest Financing through OCI | (2,200) | — |
A reconciliation of the amounts of cash and cash equivalents and restricted cash in the consolidated balance sheets to the amount in the consolidated statements of cash flows is as follows (in thousands):
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Cash and cash equivalents | $29,682 | $38,037 |
| Restricted cash included in other long-term assets | 386 | 384 |
| Cash and cash equivalents and restricted cash shown in the statement of cash flows | $30,068 | $38,421 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.